265 related articles for article (PubMed ID: 9522212)
21. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
22. Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
Curtis MW; Evans AJ; Srigley JR
Mod Pathol; 2005 Apr; 18(4):585-90. PubMed ID: 15778694
[TBL] [Abstract][Full Text] [Related]
23. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.
Loy TS; Calaluce RD
Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint.
Kamoi S; AlJuboury MI; Akin MR; Silverberg SG
Int J Gynecol Pathol; 2002 Jul; 21(3):217-23. PubMed ID: 12068166
[TBL] [Abstract][Full Text] [Related]
25. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
26. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma in females detected in serous effusions. Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20.
Longatto Filho A; Bisi H; Alves VA; Kanamura CT; Oyafuso MS; Bortolan J; Lombardo V
Acta Cytol; 1997; 41(4):961-71. PubMed ID: 9250286
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
29. Common epithelial ovarian tumors. Immunohistochemical intermediate filament profiles.
Dabbs DJ; Geisinger KR
Cancer; 1988 Jul; 62(2):368-74. PubMed ID: 2454722
[TBL] [Abstract][Full Text] [Related]
30. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
[TBL] [Abstract][Full Text] [Related]
31. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
32. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
33. Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma.
Mai KT; Landry DC; Collins JP
Tumori; 2002; 88(4):341-4. PubMed ID: 12400988
[TBL] [Abstract][Full Text] [Related]
34. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
35. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
DeCostanzo DC; Elias JM; Chumas JC
Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
[TBL] [Abstract][Full Text] [Related]
36. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
[TBL] [Abstract][Full Text] [Related]
38. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
39. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
40. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
Ordóñez NG
Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]